Flagship Pioneering announced on November 16, 2026, that it will establish the Flagship Origination Lab, U.K., in London—its first dedicated company-creation unit outside the United States. The firm committed an initial £100 million (about US$132 million) to launch the lab. It aims to attract a further £500 million through partnerships; that additional funding is an aspiration, not yet secured. The lab will develop, test, fund, and build AI-native companies spanning human and planetary health and other areas of science. Flagship says AI will be used throughout the company-building process. Flagship expects to recruit an initial team of about 50 scientist-entrepreneurs and operators. Reuters reported the firm hopes to build eight to 10 UK-based biotechs over the next few years. Unlike a conventional venture fund investing mainly in existing startups, Flagship says it plans to create new companies, working with universities, corporations, and other partners. Sources: Venture ...
- Get link
- X
- Other Apps